Effect of docosahexaenoic acid supplementation on the macular function of patients with Best vitelliform macular dystrophy: Randomized clinical trial

Canadian Journal of Ophthalmology

Volumn 45, Issue 5, 2010, Pages 514-519

  Lee, Thomas K M ^a   Clandinin, M Thomas ^b   Hébert, Marc ^c   MacDonald, Ian M ^a  

^a ROYAL ALEXANDRA HOSPITAL   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Best dystrophy; Clinical trial; Docosahexaenoic acid

Indexed keywords

DOCOSAHEXAENOIC ACID; PLACEBO;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROOCULOGRAM; ELECTRORETINOGRAM; HUMAN; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA LUTEA; RETINA MACULA VITELLIFORM DEGENERATION; VF 14 QUESTIONNAIRE; VISION; VISUAL ACUITY; VISUAL FIELD;

EID: 77957371559     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i10-028     Document Type: Article

References (31)

1. Giusto NM, Pasquare SJ, Salvador GA, Castagnet PI, Roque ME, Ilincheta de Boschero MG. Lipid metabolism in vertebrate retinal rod outer segments. Prog Lipid Res 2000;39:315-91.
2. Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985;24:169-76.
3. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr-/-mice. Proc Natl Acad Sci U S A 1999;96:13995-14000.
4. Leifert WR, McMurchie EJ, Saint DA. Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids. J Physiol 1999;520:671-9.
5. Best F. Ueber eine hereditaere Makulaaffection. Beitraege zur Vererbungslehre. Zschr Augenheilk 1905;13:199-212.
6. Fishman GA, Baca W, Alexander KR, Derlacki DJ, Glenn AM, VianaM. Visual acuity in patients with Best vitelliformmacular dystrophy. Ophthalmology 1993;100:1665-70.
7. Loewenstein A, Godel V, Godel L, Lazar M. Variable phenotypic expressivity of Best's vitelliform dystrophy. Ophthalmic Paediatr Genet 1993;14:131-6. (Pubitemid 24016968)
8. Scholl HP, Schuster AM, Vonthein R, Zrenner E. Mapping of retinal function in Best macular dystrophy using multifocal electroretinography. Vision Res 2002;42:1053-61. (Pubitemid 34270528)
9. Palmowski AM, Allgayer R, Heinemann-Vernaleken, Scherer V, Ruprecht KW. Detection of retinal dysfunction in vitelliform macular dystrophy using the multifocal ERG (MF-ERG). Doc Ophthalmol 2003;106:145-52. (Pubitemid 36355956)
10. Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci USA 2002;99:4008-13. (Pubitemid 34252220)
11. Marmorstein LY, Wu J, McLaughlin P, et al. The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1). J Gen Physiol 2006;127:577-89.
12. Rosenthal R, Bakall B, Kinnick T, et al. Expression of bestrophin- 1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. FASEB J 2006;20:178-80. (Pubitemid 43100506)
13. Cho E, Hung S, Willett WC, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 2001;73:209-18. (Pubitemid 32109848)
14. Gordon WC, Bazan NG. Retina. In: Harding JJ, ed. Biochemistry of the Eye. 1st ed. London: Chapman & Hall; 1997:144-275.
15. Litman BJ, Niu SL, Polozova A, Mitchell DC. The role of docosahexaenoic acid containing phospholipids in modulating G protein-coupled signaling pathways: visual transduction. J Mol Neurosci 2001;16:237-42. (Pubitemid 32664785)
16. Rotstein NP, Aveldano MI, Barrantes FJ, Roccamo AM, Politi LE. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J Neurochem 1997;69:504-13.
17. O'Gorman S, Flaherty WA, Fishman GA, Berson EL. Histopathologic findings in Best's vitelliform macular dystrophy. Arch Ophthalmol 1988;106:1261-8.
18. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M. Effect of an 8-month treatment withomega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. J Parenter Enteral Nutr 2003;27:52-7. (Pubitemid 36105644)
19. Mohler CW, Fine SL. Long-term evaluation of patients with Best's vitelliform dystrophy. Ophthalmology 1981;88:688-92.
20. Moriguchi T, Loewke J, Garrison M, Catalan JN, Salem Jr. N. Reversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum. J Lipid Res 2001;42:419-27. (Pubitemid 32270066)
21. MacDonald IM, Hebert M, Yau RJ, et al. Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant stargardt-like retinal dystrophy. Br J Ophthalmol 2004;88:305-6. (Pubitemid 38142111)
22. Brown M, Marmor MF, Vaegan, Zrenner E, Brigell M, Bach M. ISCEV standard for clinical electro-oculography (EOG). Doc Ophthalmol 2006;113:205-12. (Pubitemid 44835005)
23. Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y. Guidelines for basic multifocal electroretinography. Doc Ophthalmol 2003;106:105-15.
24. Suh M, Wierzbicki AA, Lien EL, Clandinin MT. Dietary 20:4n-6 and 22:6n-3 modulates the profile of long- and very-long-chain fatty acids, rhodopsin content, and kinetics in developing photoreceptor cells. Pediatr Res 2000;48:524-30.
25. White K, Marquardt A, Weber BH. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies. Hum Mutat 2000;15:301-8. (Pubitemid 30194719)
26. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Ret Eye Res 2005;24:87-138. (Pubitemid 39535157)
27. SanGiovanni JP, Chew EY, Agron E, et al. The relationship of dietary ω-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration, AREDS report no. 23. Arch Ophthalmol 2008;126:1274-9.
28. Birch DG, Birch EE, Hoffman DR, Uauy RD. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids. Invest Ophthalmol Vis Sci 1992; 33:2365-76.
29. Birch EE, Birch DG, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992;33:3242-53.
30. Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 1998;44:201-9. (Pubitemid 28347897)
31. Li F, Chen H, Anderson RE. Biosynthesis of docosahexaenoate-containing glycerolipid molecular species in the retina. J Mol Neurosci 2001;16:205-14. (Pubitemid 32664781)